NATIXIS - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
NATIXIS ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$166,458
-86.3%
4,104
-78.9%
0.00%
-75.0%
Q3 2021$1,217,000
-72.7%
19,486
-66.4%
0.00%
-75.0%
Q4 2020$4,450,000
+419.9%
58,000
+191.9%
0.02%
+166.7%
Q3 2020$856,000
-65.8%
19,870
-65.7%
0.01%
-68.4%
Q2 2020$2,505,000
+966.0%
58,000
+610.8%
0.02%
+850.0%
Q1 2020$235,000
-93.6%
8,160
-85.8%
0.00%
-91.3%
Q4 2019$3,680,00057,3270.02%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders